ARTICLE | Company News
Antisoma, Imperial Cancer Research Fund deal
March 20, 2000 8:00 AM UTC
ASM exercised its option to acquire Therex huHMFG1, a humanized monoclonal antibody to treat epithelial cancers, from the Fund (see BioCentury May 4, 1998). ASM plans to move Therex, which is in Pha...